{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:51:17Z","timestamp":1791582677910,"version":"4.3.4"},"reference-count":117,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100020970","name":"Rashtriya Uchchatar Shiksha Abhiyan","doi-asserted-by":"publisher","award":["RUSA 2.0 (CBS TH3.6), Savitribai Phule Pune University"],"award-info":[{"award-number":["RUSA 2.0 (CBS TH3.6), Savitribai Phule Pune University"]}],"id":[{"id":"10.13039\/501100020970","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010710","name":"Savitribai Phule Pune University","doi-asserted-by":"publisher","award":["ASPIRE (2022-2024)-20TEC000835"],"award-info":[{"award-number":["ASPIRE (2022-2024)-20TEC000835"]}],"id":[{"id":"10.13039\/501100010710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12899-0","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T08:15:12Z","timestamp":1791533712000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The sphingolipid code of cancer: divergent roles across tumor types and therapeutic horizons"],"prefix":"10.1007","volume":"53","author":[{"given":"Deepak Ganpatrao","family":"Thombre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal Arun","family":"Katre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailza","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Vaish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,9]]},"reference":[{"issue":"3","key":"12899_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"12899_CR2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nrm2329","volume":"9","author":"YA Hannun","year":"2008","unstructured":"Hannun YA, Obeid LM (2008) Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 9(2):139\u2013150","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"12899_CR3","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nrc.2017.96","volume":"18","author":"B Ogretmen","year":"2018","unstructured":"Ogretmen B (2018) Sphingolipid metabolism in cancer signalling and therapy. Nat Rev Cancer 18(1):33\u201350","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"12899_CR4","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1042\/BJ20111626","volume":"441","author":"TD Mullen","year":"2012","unstructured":"Mullen TD, Hannun YA, Obeid LM (2012) Ceramide synthases at the centre of sphingolipid metabolism and biology. Biochem J 441(3):789\u2013802","journal-title":"Biochem J"},{"issue":"5","key":"12899_CR5","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/S0962-8924(98)01249-5","volume":"8","author":"S Ichikawa","year":"1998","unstructured":"Ichikawa S, Hirabayashi Y (1998) Glucosylceramide synthase and glycosphingolipid synthesis. Trends Cell Biol 8(5):198\u2013202","journal-title":"Trends Cell Biol"},{"issue":"13","key":"12899_CR6","doi-asserted-by":"publisher","first-page":"8517","DOI":"10.1074\/jbc.M707107200","volume":"283","author":"A Boath","year":"2008","unstructured":"Boath A et al (2008) Regulation and traffic of ceramide 1-phosphate produced by ceramide kinase: comparative analysis to glucosylceramide and sphingomyelin. J Biol Chem 283(13):8517\u20138526","journal-title":"J Biol Chem"},{"issue":"2","key":"12899_CR7","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.cellsig.2006.07.001","volume":"19","author":"M Tani","year":"2007","unstructured":"Tani M, Ito M, Igarashi Y (2007) Ceramide\/sphingosine\/sphingosine 1-phosphate metabolism on the cell surface and in the extracellular space. Cell Signal 19(2):229\u2013237","journal-title":"Cell Signal"},{"key":"12899_CR8","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jbior.2016.10.002","volume":"63","author":"N Coant","year":"2017","unstructured":"Coant N et al (2017) Ceramidases, roles in sphingolipid metabolism and in health and disease. Adv Biol Regul 63:122\u2013131","journal-title":"Adv Biol Regul"},{"issue":"7503","key":"12899_CR9","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nature13475","volume":"510","author":"M Maceyka","year":"2014","unstructured":"Maceyka M, Spiegel S (2014) Sphingolipid metabolites in inflammatory disease. Nature 510(7503):58\u201367","journal-title":"Nature"},{"issue":"46","key":"12899_CR10","doi-asserted-by":"publisher","first-page":"17384","DOI":"10.1073\/pnas.0600050103","volume":"103","author":"B Oskouian","year":"2006","unstructured":"Oskouian B et al (2006) Sphingosine-1-phosphate lyase potentiates apoptosis via p53- and p38-dependent pathways and is down-regulated in colon cancer. Proc Natl Acad Sci U S A 103(46):17384\u201317389","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"12899_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/med.21402","volume":"37","author":"D Vogt","year":"2017","unstructured":"Vogt D, Stark H (2017) Therapeutic Strategies and Pharmacological Tools Influencing S1P Signaling and Metabolism. Med Res Rev 37(1):3\u201351","journal-title":"Med Res Rev"},{"key":"12899_CR12","doi-asserted-by":"publisher","first-page":"107464","DOI":"10.1016\/j.pharmthera.2019.107464","volume":"207","author":"OA Sukocheva","year":"2020","unstructured":"Sukocheva OA et al (2020) Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers: A novel therapeutic target. Pharmacol Ther 207:107464","journal-title":"Pharmacol Ther"},{"issue":"7","key":"12899_CR13","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nrc2875","volume":"10","author":"NJ Pyne","year":"2010","unstructured":"Pyne NJ, Pyne S (2010) Sphingosine 1-phosphate and cancer. Nat Rev Cancer 10(7):489\u2013503","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"12899_CR14","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1002\/pros.21285","volume":"71","author":"Y Sekine","year":"2011","unstructured":"Sekine Y, Suzuki K, Remaley AT (2011) HDL and sphingosine-1-phosphate activate stat3 in prostate cancer DU145 cells via ERK1\/2 and S1P receptors, and promote cell migration and invasion. Prostate 71(7):690\u2013699","journal-title":"Prostate"},{"issue":"5","key":"12899_CR15","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.2353\/ajpath.2010.100220","volume":"177","author":"C Watson","year":"2010","unstructured":"Watson C et al (2010) High expression of sphingosine 1-phosphate receptors, S1P1 and S1P3, sphingosine kinase 1, and extracellular signal-regulated kinase-1\/2 is associated with development of tamoxifen resistance in estrogen receptor-positive breast cancer patients. Am J Pathol 177(5):2205\u20132215","journal-title":"Am J Pathol"},{"issue":"30","key":"12899_CR16","doi-asserted-by":"publisher","first-page":"26796","DOI":"10.1074\/jbc.M200754200","volume":"277","author":"LJ Siskind","year":"2002","unstructured":"Siskind LJ, Kolesnick RN, Colombini M (2002) Ceramide channels increase the permeability of the mitochondrial outer membrane to small proteins. J Biol Chem 277(30):26796\u201326803","journal-title":"J Biol Chem"},{"issue":"35","key":"12899_CR17","doi-asserted-by":"publisher","first-page":"27213","DOI":"10.1074\/jbc.M109.087791","volume":"285","author":"Y Ohkawa","year":"2010","unstructured":"Ohkawa Y et al (2010) Ganglioside GD3 enhances adhesion signals and augments malignant properties of melanoma cells by recruiting integrins to glycolipid-enriched microdomains. J Biol Chem 285(35):27213\u201327223","journal-title":"J Biol Chem"},{"issue":"1","key":"12899_CR18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000315109","volume":"26","author":"S Lucke","year":"2010","unstructured":"Lucke S, Levkau B (2010) Endothelial functions of sphingosine-1-phosphate. Cell Physiol Biochem 26(1):87\u201396","journal-title":"Cell Physiol Biochem"},{"issue":"4","key":"12899_CR19","doi-asserted-by":"publisher","first-page":"101042831769913","DOI":"10.1177\/1010428317699133","volume":"39","author":"M Nakajima","year":"2017","unstructured":"Nakajima M et al (2017) The role of sphingosine-1-phosphate in the tumor microenvironment and its clinical implications. Tumour Biol 39(4):1010428317699133","journal-title":"Tumour Biol"},{"issue":"44","key":"12899_CR20","doi-asserted-by":"publisher","first-page":"71873","DOI":"10.18632\/oncotarget.12380","volume":"7","author":"M Mrad","year":"2016","unstructured":"Mrad M et al (2016) Downregulation of sphingosine kinase-1 induces protective tumor immunity by promoting M1 macrophage response in melanoma. Oncotarget 7(44):71873\u201371886","journal-title":"Oncotarget"},{"key":"12899_CR21","doi-asserted-by":"publisher","first-page":"1564213","DOI":"10.3389\/fimmu.2025.1564213","volume":"16","author":"F Wu","year":"2025","unstructured":"Wu F et al (2025) Sphingosine-1-phosphate stimulates colorectal cancer tumor microenvironment angiogenesis and induces macrophage polarization via macrophage migration inhibitory factor. Front Immunol 16:1564213","journal-title":"Front Immunol"},{"issue":"8","key":"12899_CR22","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1038\/s44319-026-00734-3","volume":"27","author":"D Basak","year":"2026","unstructured":"Basak D et al (2026) S1P-S1PR1 signaling impairs CD8(+) T cell metabolism and effector function in tumors. EMBO Rep 27(8):2000\u20132028","journal-title":"EMBO Rep"},{"key":"12899_CR23","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/978-3-030-35582-1_7","volume":"1223","author":"G Schneider","year":"2020","unstructured":"Schneider G (2020) S1P Signaling in the Tumor Microenvironment. Adv Exp Med Biol 1223:129\u2013153","journal-title":"Adv Exp Med Biol"},{"issue":"10","key":"12899_CR24","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1002\/cac2.70047","volume":"45","author":"Y Zhan","year":"2025","unstructured":"Zhan Y et al (2025) Targeting SPHK1 in macrophages remodels the tumor microenvironment and enhances anti-PD-1 immunotherapy efficacy in colorectal cancer liver metastasis. Cancer Commun (Lond) 45(10):1203\u20131228","journal-title":"Cancer Commun (Lond)"},{"key":"12899_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4419-6741-1_1","volume":"688","author":"CR Gault","year":"2010","unstructured":"Gault CR, Obeid LM, Hannun YA (2010) An overview of sphingolipid metabolism: from synthesis to breakdown. Adv Exp Med Biol 688:1\u201323","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"12899_CR26","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.plipres.2007.03.001","volume":"46","author":"A Kihara","year":"2007","unstructured":"Kihara A et al (2007) Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate. Prog Lipid Res 46(2):126\u2013144","journal-title":"Prog Lipid Res"},{"key":"12899_CR27","doi-asserted-by":"publisher","first-page":"732","DOI":"10.3389\/fonc.2020.00732","volume":"10","author":"T Zhang","year":"2020","unstructured":"Zhang T et al (2020) Differential O- and Glycosphingolipid Glycosylation in Human Pancreatic Adenocarcinoma Cells With Opposite Morphology and Metastatic Behavior. Front Oncol 10:732","journal-title":"Front Oncol"},{"key":"12899_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/B978-0-12-394274-6.00002-9","volume":"117","author":"SA Saddoughi","year":"2013","unstructured":"Saddoughi SA, Ogretmen B (2013) Diverse functions of ceramide in cancer cell death and proliferation. Adv Cancer Res 117:37\u201358","journal-title":"Adv Cancer Res"},{"issue":"3","key":"12899_CR29","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/(SICI)1097-0142(19970201)79:3<448::AID-CNCR4>3.0.CO;2-E","volume":"79","author":"E Hertervig","year":"1997","unstructured":"Hertervig E et al (1997) Alkaline sphingomyelinase activity is decreased in human colorectal carcinoma. Cancer 79(3):448\u2013453","journal-title":"Cancer"},{"issue":"17","key":"12899_CR30","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.2174\/1568026619666190227222930","volume":"19","author":"Y Vijayan","year":"2019","unstructured":"Vijayan Y, Lankadasari MB, Harikumar KB (2019) Acid Ceramidase: A Novel Therapeutic Target in Cancer. Curr Top Med Chem 19(17):1512\u20131520","journal-title":"Curr Top Med Chem"},{"issue":"12","key":"12899_CR31","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1194\/jlr.M085191","volume":"59","author":"MA Maczis","year":"2018","unstructured":"Maczis MA et al (2018) Sphingosine kinase 1 activation by estrogen receptor \u03b136 contributes to tamoxifen resistance in breast cancer. J Lipid Res 59(12):2297\u20132307","journal-title":"J Lipid Res"},{"key":"12899_CR32","doi-asserted-by":"crossref","unstructured":"Markowski AR et al (2023) The Effect of Silencing the Genes Responsible for the Level of Sphingosine-1-phosphate on the Apoptosis of Colon Cancer Cells. Int J Mol Sci 24(8):7197","DOI":"10.3390\/ijms24087197"},{"issue":"4","key":"12899_CR33","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1158\/1078-0432.CCR-08-1158","volume":"15","author":"W Li","year":"2009","unstructured":"Li W et al (2009) Sphingosine kinase 1 is associated with gastric cancer progression and poor survival of patients. Clin Cancer Res 15(4):1393\u20131399","journal-title":"Clin Cancer Res"},{"issue":"2","key":"12899_CR34","first-page":"1259","volume":"18","author":"M Gachechiladze","year":"2019","unstructured":"Gachechiladze M et al (2019) Sphingosine kinase-1 predicts overall survival outcomes in non-small cell lung cancer patients treated with carboplatin and navelbine. Oncol Lett 18(2):1259\u20131266","journal-title":"Oncol Lett"},{"issue":"11","key":"12899_CR35","doi-asserted-by":"publisher","first-page":"4570","DOI":"10.1111\/cas.15123","volume":"112","author":"T Taniai","year":"2021","unstructured":"Taniai T et al (2021) Inhibition of acid ceramidase elicits mitochondrial dysfunction and oxidative stress in pancreatic cancer cells. Cancer Sci 112(11):4570\u20134579","journal-title":"Cancer Sci"},{"issue":"8","key":"12899_CR36","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1097\/01.jnen.0000175329.59092.2c","volume":"64","author":"JR Van Brocklyn","year":"2005","unstructured":"Van Brocklyn JR et al (2005) Sphingosine kinase-1 expression correlates with poor survival of patients with glioblastoma multiforme: roles of sphingosine kinase isoforms in growth of glioblastoma cell lines. J Neuropathol Exp Neurol 64(8):695\u2013705","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"12899_CR37","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nrc3398","volume":"13","author":"SA Morad","year":"2013","unstructured":"Morad SA, Cabot MC (2013) Ceramide-orchestrated signalling in cancer cells. Nat Rev Cancer 13(1):51\u201365","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"12899_CR38","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.tcb.2011.09.003","volume":"22","author":"M Maceyka","year":"2012","unstructured":"Maceyka M et al (2012) Sphingosine-1-phosphate signaling and its role in disease. Trends Cell Biol 22(1):50\u201360","journal-title":"Trends Cell Biol"},{"issue":"8","key":"12899_CR39","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/sj.leu.2402197","volume":"15","author":"PP Ruvolo","year":"2001","unstructured":"Ruvolo PP (2001) Ceramide regulates cellular homeostasis via diverse stress signaling pathways. Leukemia 15(8):1153\u20131160","journal-title":"Leukemia"},{"issue":"21","key":"12899_CR40","doi-asserted-by":"publisher","first-page":"5317","DOI":"10.1111\/febs.12314","volume":"280","author":"HA Neubauer","year":"2013","unstructured":"Neubauer HA, Pitson SM (2013) Roles, regulation and inhibitors of sphingosine kinase 2. Febs j 280(21):5317\u20135336","journal-title":"Febs j"},{"issue":"2","key":"12899_CR41","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1172\/JCI1180","volume":"102","author":"GS Dbaibo","year":"1998","unstructured":"Dbaibo GS et al (1998) p53-dependent ceramide response to genotoxic stress. J Clin Invest 102(2):329\u2013339","journal-title":"J Clin Invest"},{"issue":"6","key":"12899_CR42","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1074\/jbc.M708241200","volume":"283","author":"V Anelli","year":"2008","unstructured":"Anelli V et al (2008) Sphingosine kinase 1 is up-regulated during hypoxia in U87MG glioma cells. Role of hypoxia-inducible factors 1 and 2. J Biol Chem 283(6):3365\u20133375","journal-title":"J Biol Chem"},{"issue":"1","key":"12899_CR43","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/sj.leu.2404023","volume":"20","author":"E Bonhoure","year":"2006","unstructured":"Bonhoure E et al (2006) Overcoming MDR-associated chemoresistance in HL-60 acute myeloid leukemia cells by targeting sphingosine kinase-1. Leukemia 20(1):95\u2013102","journal-title":"Leukemia"},{"key":"12899_CR44","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jare.2023.12.013","volume":"65","author":"Y Vijayan","year":"2024","unstructured":"Vijayan Y et al (2024) Targeting acid ceramidase enhances antitumor immune response in colorectal cancer. J Adv Res 65:73\u201387","journal-title":"J Adv Res"},{"issue":"1","key":"12899_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2008.02.020","volume":"264","author":"A Carpinteiro","year":"2008","unstructured":"Carpinteiro A et al (2008) Ceramide-induced cell death in malignant cells. Cancer Lett 264(1):1\u201310","journal-title":"Cancer Lett"},{"issue":"3","key":"12899_CR46","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/CAD.0b013e328340bd95","volume":"22","author":"T Fuereder","year":"2011","unstructured":"Fuereder T et al (2011) Sphingosine kinase 1 is a relevant molecular target in gastric cancer. Anticancer Drugs 22(3):245\u2013252","journal-title":"Anticancer Drugs"},{"key":"12899_CR47","doi-asserted-by":"publisher","first-page":"120731","DOI":"10.1016\/j.cca.2025.120731","volume":"580","author":"X Ding","year":"2026","unstructured":"Ding X et al (2026) Lipidomic machine learning predictor for progression of gastric cancer. Clin Chim Acta 580:120731","journal-title":"Clin Chim Acta"},{"issue":"1","key":"12899_CR48","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1186\/s12935-024-03535-7","volume":"24","author":"KR Limbu","year":"2024","unstructured":"Limbu KR et al (2024) Targeting sphingosine 1-phosphate and sphingosine kinases in pancreatic cancer: mechanisms and therapeutic potential. Cancer Cell Int 24(1):353","journal-title":"Cancer Cell Int"},{"key":"12899_CR49","doi-asserted-by":"crossref","unstructured":"Pal P, Atilla-Gokcumen GE, Frasor J (2022) Emerging Roles of Ceramides in Breast Cancer Biology and Therapy. Int J Mol Sci 23(19):11178","DOI":"10.3390\/ijms231911178"},{"issue":"2","key":"12899_CR50","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1042\/BJ20051184","volume":"395","author":"A Prinetti","year":"2006","unstructured":"Prinetti A et al (2006) Lack of ceramide generation and altered sphingolipid composition are associated with drug resistance in human ovarian carcinoma cells. Biochem J 395(2):311\u2013318","journal-title":"Biochem J"},{"issue":"3","key":"12899_CR51","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/PGP.0b013e3182673982","volume":"32","author":"LC Hanker","year":"2013","unstructured":"Hanker LC et al (2013) Acid ceramidase (AC)--a key enzyme of sphingolipid metabolism\u2013correlates with better prognosis in epithelial ovarian cancer. Int J Gynecol Pathol 32(3):249\u2013257","journal-title":"Int J Gynecol Pathol"},{"issue":"1\u20134","key":"12899_CR52","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.prostaglandins.2010.03.002","volume":"92","author":"P Knapp","year":"2010","unstructured":"Knapp P et al (2010) Altered sphingolipid metabolism in human endometrial cancer. Prostaglandins Other Lipid Mediat 92(1\u20134):62\u201366","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"12899_CR53","doi-asserted-by":"crossref","unstructured":"B\u0142achnio-Zabielska AU et al (2024) The Interplay between Oxidative Stress and Sphingolipid Metabolism in Endometrial Cancer. Int J Mol Sci, 25(19):10243","DOI":"10.3390\/ijms251910243"},{"issue":"10","key":"12899_CR54","doi-asserted-by":"publisher","first-page":"4343","DOI":"10.1021\/acs.jproteome.4c00344","volume":"23","author":"J Zhang","year":"2024","unstructured":"Zhang J et al (2024) Alterations of Ceramides, Acylcarnitines, GlyceroLPLs, and Amines in NSCLC Tissues. J Proteome Res 23(10):4343\u20134358","journal-title":"J Proteome Res"},{"issue":"2","key":"12899_CR55","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1247\/csf.18026","volume":"43","author":"S Ishihara","year":"2018","unstructured":"Ishihara S et al (2018) Glycosphingolipid GM2 Induces Invasiveness in Irradiation-tolerant Lung Cancer Cells. Cell Struct Funct 43(2):177\u2013185","journal-title":"Cell Struct Funct"},{"key":"12899_CR56","doi-asserted-by":"crossref","unstructured":"Hawkins CC et al (2022) Targeting Acid Ceramidase Inhibits Glioblastoma Cell Migration through Decreased AKT Signaling. Cells 11(12):1873","DOI":"10.3390\/cells11121873"},{"issue":"5","key":"12899_CR57","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1074\/jbc.M115.666909","volume":"291","author":"N Realini","year":"2016","unstructured":"Realini N et al (2016) Acid Ceramidase in Melanoma: EXPRESSION, LOCALIZATION, AND EFFECTS OF PHARMACOLOGICAL INHIBITION. J Biol Chem 291(5):2422\u20132434","journal-title":"J Biol Chem"},{"issue":"8","key":"12899_CR58","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1002\/1878-0261.12702","volume":"14","author":"RI Ramos","year":"2020","unstructured":"Ramos RI et al (2020) Upregulation of cell surface GD3 ganglioside phenotype is associated with human melanoma brain metastasis. Mol Oncol 14(8):1760\u20131778","journal-title":"Mol Oncol"},{"issue":"57","key":"12899_CR59","doi-asserted-by":"publisher","first-page":"7904","DOI":"10.1038\/sj.onc.1210587","volume":"26","author":"QF Li","year":"2007","unstructured":"Li QF et al (2007) Sphingosine kinase-1 mediates BCR\/ABL-induced upregulation of Mcl-1 in chronic myeloid leukemia cells. Oncogene 26(57):7904\u20137908","journal-title":"Oncogene"},{"issue":"10","key":"12899_CR60","doi-asserted-by":"publisher","first-page":"7138","DOI":"10.1074\/jbc.275.10.7138","volume":"275","author":"YY Liu","year":"2000","unstructured":"Liu YY et al (2000) Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisense reverses adriamycin resistance. J Biol Chem 275(10):7138\u20137143","journal-title":"J Biol Chem"},{"issue":"1","key":"12899_CR61","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/sj.cdd.4400307","volume":"5","author":"B Brenner","year":"1998","unstructured":"Brenner B et al (1998) Fas\/CD95\/Apo-I activates the acidic sphingomyelinase via caspases. Cell Death Differ 5(1):29\u201337","journal-title":"Cell Death Differ"},{"issue":"11","key":"12899_CR62","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1158\/1535-7163.MCT-11-0365","volume":"10","author":"JM Draper","year":"2011","unstructured":"Draper JM et al (2011) Discovery and evaluation of inhibitors of human ceramidase. Mol Cancer Ther 10(11):2052\u20132061","journal-title":"Mol Cancer Ther"},{"issue":"12","key":"12899_CR63","doi-asserted-by":"publisher","first-page":"9078","DOI":"10.1074\/jbc.275.12.9078","volume":"275","author":"DK Perry","year":"2000","unstructured":"Perry DK et al (2000) Serine palmitoyltransferase regulates de novo ceramide generation during etoposide-induced apoptosis. J Biol Chem 275(12):9078\u20139084","journal-title":"J Biol Chem"},{"issue":"1","key":"12899_CR64","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1158\/0008-5472.CAN-05-2001","volume":"66","author":"K LaMontagne","year":"2006","unstructured":"LaMontagne K et al (2006) Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization. Cancer Res 66(1):221\u2013231","journal-title":"Cancer Res"},{"key":"12899_CR65","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/B978-0-12-391860-4.00005-7","volume":"508","author":"RJ Watters","year":"2012","unstructured":"Watters RJ et al (2012) Development and use of ceramide nanoliposomes in cancer. Methods Enzymol 508:89\u2013108","journal-title":"Methods Enzymol"},{"issue":"1","key":"12899_CR66","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S1091-255X(02)00126-9","volume":"7","author":"DA Litvak","year":"2003","unstructured":"Litvak DA, Bilchik AJ, Cabot MC (2003) Modulators of ceramide metabolism sensitize colorectal cancer cells to chemotherapy: a novel treatment strategy. J Gastrointest Surg 7(1):140\u2013148","journal-title":"J Gastrointest Surg"},{"key":"12899_CR67","doi-asserted-by":"crossref","unstructured":"Gupta P et al (2021) Targeting the Sphingosine Kinase\/Sphingosine-1-Phosphate Signaling Axis in Drug Discovery for Cancer Therapy. Cancers (Basel) 13(8):1898","DOI":"10.3390\/cancers13081898"},{"issue":"5","key":"12899_CR68","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1093\/jn\/124.5.615","volume":"124","author":"DL Dillehay","year":"1994","unstructured":"Dillehay DL et al (1994) Dietary sphingomyelin inhibits 1,2-dimethylhydrazine-induced colon cancer in CF1 mice. J Nutr 124(5):615\u2013620","journal-title":"J Nutr"},{"issue":"8","key":"12899_CR69","doi-asserted-by":"publisher","first-page":"653","DOI":"10.2174\/138945008785132358","volume":"9","author":"YH Zeidan","year":"2008","unstructured":"Zeidan YH et al (2008) Molecular targeting of acid ceramidase: implications to cancer therapy. Curr Drug Targets 9(8):653\u2013661","journal-title":"Curr Drug Targets"},{"key":"12899_CR70","doi-asserted-by":"publisher","first-page":"959170","DOI":"10.3389\/fgene.2022.959170","volume":"13","author":"J Zeng","year":"2022","unstructured":"Zeng J et al (2022) Lipid metabolism characterization in gastric cancer identifies signatures to predict prognostic and therapeutic responses. Front Genet 13:959170","journal-title":"Front Genet"},{"issue":"1","key":"12899_CR71","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jss.2005.08.004","volume":"130","author":"H Yamashita","year":"2006","unstructured":"Yamashita H et al (2006) Sphingosine 1-phosphate receptor expression profile in human gastric cancer cells: differential regulation on the migration and proliferation. J Surg Res 130(1):80\u201387","journal-title":"J Surg Res"},{"key":"12899_CR72","doi-asserted-by":"crossref","unstructured":"Xu J et al (2023) Transcriptome and Lipidomic Analysis Suggests Lipid Metabolism Reprogramming and Upregulating SPHK1 Promotes Stemness in Pancreatic Ductal Adenocarcinoma Stem-like Cells. Metabolites 13(11):1132","DOI":"10.3390\/metabo13111132"},{"issue":"4","key":"12899_CR73","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1158\/1535-7163.MCT-08-1096","volume":"8","author":"J Guillermet-Guibert","year":"2009","unstructured":"Guillermet-Guibert J et al (2009) Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug. Mol Cancer Ther 8(4):809\u2013820","journal-title":"Mol Cancer Ther"},{"issue":"6","key":"12899_CR74","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1007\/s12033-024-01192-9","volume":"67","author":"M Yu","year":"2025","unstructured":"Yu M et al (2025) SPHK1 Promotes Pancreatic Cancer Lymphangiogenesis Through the Activation of ERK in LECs. Mol Biotechnol 67(6):2246\u20132253","journal-title":"Mol Biotechnol"},{"key":"12899_CR75","doi-asserted-by":"publisher","first-page":"748470","DOI":"10.3389\/fmolb.2021.748470","volume":"8","author":"LW Hii","year":"2021","unstructured":"Hii LW et al (2021) Sphingosine Kinase 1 Signaling in Breast Cancer: A Potential Target to Tackle Breast Cancer Stem Cells. Front Mol Biosci 8:748470","journal-title":"Front Mol Biosci"},{"issue":"2","key":"12899_CR76","first-page":"425","volume":"39","author":"YY Liu","year":"2011","unstructured":"Liu YY et al (2011) Glucosylceramide synthase, a factor in modulating drug resistance, is overexpressed in metastatic breast carcinoma. Int J Oncol 39(2):425\u2013431","journal-title":"Int J Oncol"},{"issue":"6","key":"12899_CR77","doi-asserted-by":"publisher","first-page":"7180","DOI":"10.1096\/fj.201801635R","volume":"33","author":"W Wang","year":"2019","unstructured":"Wang W et al (2019) Sphingosine 1-phosphate signaling induces SNAI2 expression to promote cell invasion in breast cancer cells. Faseb j 33(6):7180\u20137191","journal-title":"Faseb j"},{"issue":"1","key":"12899_CR78","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/CAD.0000000000000566","volume":"29","author":"HS Vethakanraj","year":"2018","unstructured":"Vethakanraj HS et al (2018) Anticancer effect of acid ceramidase inhibitor ceranib-2 in human breast cancer cell lines MCF-7, MDA MB-231 by the activation of SAPK\/JNK, p38 MAPK apoptotic pathways, inhibition of the Akt pathway, downregulation of ER\u03b1. Anticancer Drugs 29(1):50\u201360","journal-title":"Anticancer Drugs"},{"key":"12899_CR79","doi-asserted-by":"publisher","first-page":"181","DOI":"10.20517\/cdr.2018.06","volume":"1","author":"KM Kreitzburg","year":"2018","unstructured":"Kreitzburg KM, van Waardenburg R, Yoon KJ (2018) Sphingolipid metabolism and drug resistance in ovarian cancer. Cancer Drug Resist 1:181\u2013197","journal-title":"Cancer Drug Resist"},{"issue":"12","key":"12899_CR80","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1016\/j.bbamem.2006.08.012","volume":"1758","author":"V Gouaze-Andersson","year":"2006","unstructured":"Gouaze-Andersson V, Cabot MC (2006) Glycosphingolipids and drug resistance. Biochim Biophys Acta 1758(12):2096\u20132103","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"12899_CR81","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3892\/ol.2016.4661","volume":"12","author":"YE Zeng","year":"2016","unstructured":"Zeng YE et al (2016) Potential signaling pathway involved in sphingosine-1-phosphate-induced epithelial-mesenchymal transition in cancer. Oncol Lett 12(1):379\u2013382","journal-title":"Oncol Lett"},{"key":"12899_CR82","doi-asserted-by":"crossref","unstructured":"Qin Z et al (2021) SPHK1 contributes to cisplatin resistance in bladder cancer cells via the NONO\/STAT3 axis. Int J Mol Med 48(5):204","DOI":"10.3892\/ijmm.2021.5037"},{"issue":"3","key":"12899_CR83","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2174\/1568009620666201223154621","volume":"21","author":"HS Vethakanraj","year":"2021","unstructured":"Vethakanraj HS, Chandrasekaran N, Sekar AK (2021) Acid Ceramidase, a Double-edged Sword in Cancer Aggression: A Minireview. Curr Cancer Drug Targets 21(3):177\u2013191","journal-title":"Curr Cancer Drug Targets"},{"issue":"1","key":"12899_CR84","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s13277-013-1051-1","volume":"35","author":"Q Wang","year":"2014","unstructured":"Wang Q et al (2014) Prognostic significance of sphingosine kinase 2 expression in non-small cell lung cancer. Tumour Biol 35(1):363\u2013368","journal-title":"Tumour Biol"},{"key":"12899_CR85","doi-asserted-by":"crossref","unstructured":"Afrin F et al (2023) Natural Products and Small Molecules Targeting Cellular Ceramide Metabolism to Enhance Apoptosis in Cancer Cells. Cancers (Basel) 15(18):4645","DOI":"10.3390\/cancers15184645"},{"issue":"7","key":"12899_CR86","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1158\/1078-0432.CCR-10-0720","volume":"17","author":"L Song","year":"2011","unstructured":"Song L et al (2011) Sphingosine kinase-1 enhances resistance to apoptosis through activation of PI3K\/Akt\/NF-\u03baB pathway in human non-small cell lung cancer. Clin Cancer Res 17(7):1839\u20131849","journal-title":"Clin Cancer Res"},{"issue":"3","key":"12899_CR87","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1158\/1541-7786.MCR-08-0156","volume":"7","author":"SE Schnitzer","year":"2009","unstructured":"Schnitzer SE et al (2009) Hypoxia enhances sphingosine kinase 2 activity and provokes sphingosine-1-phosphate-mediated chemoresistance in A549 lung cancer cells. Mol Cancer Res 7(3):393\u2013401","journal-title":"Mol Cancer Res"},{"key":"12899_CR88","doi-asserted-by":"crossref","unstructured":"Shi Y et al (2021) Ceramide induces the apoptosis of non\u2013small cell lung cancer cells through the Txnip\/Trx1 complex. Int J Mol Med 47(5):85","DOI":"10.3892\/ijmm.2021.4918"},{"issue":"2","key":"12899_CR89","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.canlet.2013.04.034","volume":"337","author":"PP Adiseshaiah","year":"2013","unstructured":"Adiseshaiah PP et al (2013) Synergistic combination therapy with nanoliposomal C6-ceramide and vinblastine is associated with autophagy dysfunction in hepatocarcinoma and colorectal cancer models. Cancer Lett 337(2):254\u2013265","journal-title":"Cancer Lett"},{"issue":"68","key":"12899_CR90","doi-asserted-by":"publisher","first-page":"112662","DOI":"10.18632\/oncotarget.22637","volume":"8","author":"NB Doan","year":"2017","unstructured":"Doan NB et al (2017) Acid ceramidase and its inhibitors: a de novo drug target and a new class of drugs for killing glioblastoma cancer stem cells with high efficiency. Oncotarget 8(68):112662\u2013112674","journal-title":"Oncotarget"},{"issue":"12","key":"12899_CR91","doi-asserted-by":"publisher","first-page":"4390","DOI":"10.1016\/j.apsb.2022.09.012","volume":"12","author":"W Li","year":"2022","unstructured":"Li W et al (2022) Sphingosine kinase 1 promotes growth of glioblastoma by increasing inflammation mediated by the NF-\u03baB \/IL-6\/STAT3 and JNK\/PTX3 pathways. Acta Pharm Sin B 12(12):4390\u20134406","journal-title":"Acta Pharm Sin B"},{"issue":"5945","key":"12899_CR92","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.1176709","volume":"325","author":"NC Hait","year":"2009","unstructured":"Hait NC et al (2009) Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. Science 325(5945):1254\u20131257","journal-title":"Science"},{"issue":"4","key":"12899_CR93","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.3892\/or.2017.5855","volume":"38","author":"NB Doan","year":"2017","unstructured":"Doan NB et al (2017) Acid ceramidase confers radioresistance to glioblastoma cells. Oncol Rep 38(4):1932\u20131940","journal-title":"Oncol Rep"},{"issue":"1","key":"12899_CR94","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/jcb.21181","volume":"101","author":"G Schmid","year":"2007","unstructured":"Schmid G et al (2007) The immunosuppressant FTY720 inhibits tumor angiogenesis via the sphingosine 1-phosphate receptor 1. J Cell Biochem 101(1):259\u2013270","journal-title":"J Cell Biochem"},{"issue":"2","key":"12899_CR95","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1755-148X.2012.00970.x","volume":"25","author":"SV Madhunapantula","year":"2012","unstructured":"Madhunapantula SV et al (2012) Targeting sphingosine kinase-1 to inhibit melanoma. Pigment Cell Melanoma Res 25(2):259\u2013274","journal-title":"Pigment Cell Melanoma Res"},{"issue":"2","key":"12899_CR96","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1128\/MCB.00554-15","volume":"36","author":"LS Campos","year":"2016","unstructured":"Campos LS et al (2016) Filamin A Expression Negatively Regulates Sphingosine-1-Phosphate-Induced NF-\u03baB Activation in Melanoma Cells by Inhibition of Akt Signaling. Mol Cell Biol 36(2):320\u2013329","journal-title":"Mol Cell Biol"},{"key":"12899_CR97","doi-asserted-by":"crossref","unstructured":"Robinson CL, Guo M (2016) Fingolimod (Gilenya) and melanoma. BMJ Case Rep. 2016:bcr2016217885","DOI":"10.1136\/bcr-2016-217885"},{"issue":"12","key":"12899_CR98","doi-asserted-by":"publisher","first-page":"3750","DOI":"10.4049\/jimmunol.1801041","volume":"201","author":"GN Shenoy","year":"2018","unstructured":"Shenoy GN et al (2018) Sialic Acid-Dependent Inhibition of T Cells by Exosomal Ganglioside GD3 in Ovarian Tumor Microenvironments. J Immunol 201(12):3750\u20133758","journal-title":"J Immunol"},{"issue":"9","key":"12899_CR99","doi-asserted-by":"publisher","first-page":"e70574","DOI":"10.1111\/jcmm.70574","volume":"29","author":"ZK Price","year":"2025","unstructured":"Price ZK et al (2025) Identification of Sphingosine Kinase 1 as a Novel Protein Regulated by High Molecular Weight Hyaluronan in Ovarian Cancer. J Cell Mol Med 29(9):e70574","journal-title":"J Cell Mol Med"},{"issue":"3","key":"12899_CR100","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.3892\/ijo.2015.3070","volume":"47","author":"M Durbas","year":"2015","unstructured":"Durbas M et al (2015) GD2 ganglioside specific antibody treatment downregulates PI3K\/Akt\/mTOR signaling network in human neuroblastoma cell lines. Int J Oncol 47(3):1143\u20131159","journal-title":"Int J Oncol"},{"key":"12899_CR101","doi-asserted-by":"crossref","unstructured":"Sheridan M, Ogretmen B (2021) The Role of Ceramide Metabolism and Signaling in the Regulation of Mitophagy and Cancer Therapy. Cancers (Basel) 13(10):2475","DOI":"10.3390\/cancers13102475"},{"issue":"1","key":"12899_CR102","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1124\/jpet.109.163444","volume":"333","author":"KJ French","year":"2010","unstructured":"French KJ et al (2010) Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2. J Pharmacol Exp Ther 333(1):129\u2013139","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"12899_CR103","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1042\/BJ20111929","volume":"444","author":"ME Schnute","year":"2012","unstructured":"Schnute ME et al (2012) Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1. Biochem J 444(1):79\u201388","journal-title":"Biochem J"},{"issue":"1","key":"12899_CR104","doi-asserted-by":"publisher","first-page":"100926","DOI":"10.1016\/j.tranon.2020.100926","volume":"14","author":"T Rupp","year":"2021","unstructured":"Rupp T et al (2021) Therapeutic potential of Fingolimod in triple negative breast cancer preclinical models. Transl Oncol 14(1):100926","journal-title":"Transl Oncol"},{"issue":"10127","key":"12899_CR105","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/S0140-6736(18)30475-6","volume":"391","author":"L Kappos","year":"2018","unstructured":"Kappos L et al (2018) Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study. Lancet 391(10127):1263\u20131273","journal-title":"Lancet"},{"key":"12899_CR106","doi-asserted-by":"publisher","first-page":"9275","DOI":"10.1038\/srep09275","volume":"5","author":"P Zhang","year":"2015","unstructured":"Zhang P et al (2015) C6-ceramide nanoliposome suppresses tumor metastasis by eliciting PI3K and PKC\u03b6 tumor-suppressive activities and regulating integrin affinity modulation. Sci Rep 5:9275","journal-title":"Sci Rep"},{"issue":"11","key":"12899_CR107","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.1038\/s41591-025-03874-6","volume":"31","author":"F Locatelli","year":"2025","unstructured":"Locatelli F et al (2025) GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1\/2 trial. Nat Med 31(11):3689\u20133699","journal-title":"Nat Med"},{"issue":"10","key":"12899_CR108","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.21873\/anticanres.17257","volume":"44","author":"H Ha","year":"2024","unstructured":"Ha H et al (2024) Anticancer Effects of BAF312 (Siponimod) in Epithelial Ovarian Cancer. Anticancer Res 44(10):4273\u20134282","journal-title":"Anticancer Res"},{"issue":"3","key":"12899_CR109","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ccr.2006.02.023","volume":"9","author":"B Visentin","year":"2006","unstructured":"Visentin B et al (2006) Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages. Cancer Cell 9(3):225\u2013238","journal-title":"Cancer Cell"},{"issue":"1","key":"12899_CR110","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00280-023-04588-7","volume":"93","author":"A Ciner","year":"2024","unstructured":"Ciner A et al (2024) A phase I study of the ceramide nanoliposome in patients with advanced solid tumors. Cancer Chemother Pharmacol 93(1):23\u201329","journal-title":"Cancer Chemother Pharmacol"},{"key":"12899_CR111","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jphotobiol.2013.06.013","volume":"126","author":"M Korbelik","year":"2013","unstructured":"Korbelik M et al (2013) Cationic ceramides and analogues, LCL30 and LCL85, as adjuvants to photodynamic therapy of tumors. J Photochem Photobiol B 126:72\u201377","journal-title":"J Photochem Photobiol B"},{"issue":"1","key":"12899_CR112","doi-asserted-by":"publisher","first-page":"6970","DOI":"10.1038\/s41467-024-51495-3","volume":"15","author":"L Dong","year":"2024","unstructured":"Dong L et al (2024) Inhibition of glycosphingolipid synthesis with eliglustat in combination with immune checkpoint inhibitors in advanced cancers: preclinical evidence and phase I clinical trial. Nat Commun 15(1):6970","journal-title":"Nat Commun"},{"issue":"5","key":"12899_CR113","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/(SICI)1097-0215(20000301)85:5<659::AID-IJC11>3.0.CO;2-5","volume":"85","author":"G Ragupathi","year":"2000","unstructured":"Ragupathi G et al (2000) Induction of antibodies against GD3 ganglioside in melanoma patients by vaccination with GD3-lactone-KLH conjugate plus immunological adjuvant QS-21. Int J Cancer 85(5):659\u2013666","journal-title":"Int J Cancer"},{"issue":"46","key":"12899_CR114","doi-asserted-by":"publisher","first-page":"25435","DOI":"10.1021\/acs.analchem.5c02746","volume":"97","author":"J Zhao","year":"2025","unstructured":"Zhao J et al (2025) Lipidomic Profiling of Metastatic Lung Cancer-Derived Exosomes Unveiling Ceramides as Potential Biomarkers by Supramolecular Probe Enrichment and Mass Spectrometry Analysis. Anal Chem 97(46):25435\u201325443","journal-title":"Anal Chem"},{"issue":"1","key":"12899_CR115","doi-asserted-by":"publisher","first-page":"6124","DOI":"10.1038\/s41598-020-62823-0","volume":"10","author":"JH Jung","year":"2020","unstructured":"Jung JH et al (2020) Comparative lipidomics of 5-Fluorouracil-sensitive and -resistant colorectal cancer cells reveals altered sphingomyelin and ceramide controlled by acid sphingomyelinase (SMPD1). Sci Rep 10(1):6124","journal-title":"Sci Rep"},{"issue":"11","key":"12899_CR116","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1016\/j.bbalip.2016.08.014","volume":"1861","author":"S Krautbauer","year":"2016","unstructured":"Krautbauer S et al (2016) Ceramide and polyunsaturated phospholipids are strongly reduced in human hepatocellular carcinoma. Biochim Biophys Acta 1861(11):1767\u20131774","journal-title":"Biochim Biophys Acta"},{"issue":"24","key":"12899_CR117","doi-asserted-by":"publisher","first-page":"4979","DOI":"10.1002\/cam4.4830","volume":"11","author":"Y Pan","year":"2022","unstructured":"Pan Y et al (2022) Exosomes and their roles in the chemoresistance of pancreatic cancer. Cancer Med 11(24):4979\u20134988","journal-title":"Cancer Med"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12899-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12899-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12899-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:02:20Z","timestamp":1791579740000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12899-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,9]]},"references-count":117,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12899"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12899-0","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,9]]},"assertion":[{"value":"12 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1689"}}